The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 106: Integrating Radiation and Immunotherapy for the Treatment of Oligometastatic Disease" during the 37th Annual Meeting & Pre-Conference Programs on November 10, 2022. Available here are the presentation slides and video from the session, as permitted by presenters.
Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
Sacha Gnjatic, PhD – Icahn School of Medicine at Mount Sinai
Jillian Hunt, AOCNP – Cincinnati Cancer Advisors
Andrea Schietinger, PhD – Memorial Sloan Kettering Cancer Center
Ryan J. Sullivan, MD – Massachusetts General Hospital
Chair: Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
Niroshana Anandasabapathy, MD, PhD – Weill Cornell Medicine
Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center
Lorenzo Falchi, MD – Memorial Sloan Kettering Cancer Center
Michelle Rohlfs, APRN, FANP-BC, AOCNP – The University of Texas MD Anderson Cancer Center
The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.To view the entire program schedule (including presenter permission to post) please click here.
SITC 2022 Annual Meeting: Thursday, November 1001:01:36